Atlas Trials

A Study to Evaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque Psoriasis

Clinical trial NCT04571567 · COMPLETED

Trial details

NCT number
NCT04571567
Sponsor
Saakshi Khattri
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Psoriasis
Start date
2019-12-02
Primary completion
2022-02-22
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.